中国医药导报
中国医药期刊欢迎您 今天是   2025年4月19日星期六
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  临床医学-神经系统疾病 本期目录 | 过刊浏览 | 高级检索 |
决策辅助在首次脑卒中患者中应用效果的系统评价
张敏1      丁晓彤2      李现文3▲
1.南京大学医学院附属鼓楼医院神经内科,江苏南京   210008;
2.北京协和医学院护理学院,北京   100144;
3.南京医科大学护理学院,江苏南京   211116
Systematic evaluation of decision aids in patients with first stroke
ZHANG Min1   DING Xiaotong2   LI Xianwen3▲
1.Department of Neurology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Jiangsu Province, Nanjing   210008, China; 
2.School of Nursing, Peking Union Medical College, Beijing   100144, China; 
3.School of Nursing, Nanjing Medical University, Jiangsu Province, Nanjing   211116, China
全文: PDF (1323 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 系统评价决策辅助在首次脑卒中患者中的应用效果。 方法 检索Cochrane Library、PubMed、Embase、CINAHL、CBM、中国知网、万方数据库从建库至2021年6月公开发表的有关决策辅助在首次脑卒中患者中应用的文献。筛选文献并评价文献质量,使用RevMan 5.3软件进行meta分析。 结果 纳入5篇文献,两组死亡率(RR = 0.61,95%CI:0.20~1.88,P = 0.39)、溶栓后脑出血发生率(RR = 0.86,95%CI:0.31~2.41,P = 0.77)比较,差异无统计学意义。试验组60 min溶栓率(RR = 1.44,95%CI:1.16~1.78,P = 0.001)和溶栓决策同意率(RR = 1.12,95%CI:1.01~1.25,P = 0.03)均高于对照组,差异有统计学意义。 结论 在首次脑卒中患者中实施决策辅助可提高60 min溶栓率和溶栓决策同意率,且安全性好,值得临床进一步研究和推广。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
张敏1 丁晓彤2 李现文3▲
关键词 决策辅助卒中meta分析系统评价    
Abstract:Objective To systematically evaluate the effect of decision aids in patients with first stroke. Methods Literatures on the application of decision aids in first stroke patients from the inception to June, 2021 of the Cochrane Library, PubMed, Embase, CINAHL, CBM, CNKI, and Wanfang Data were searched. The literatures were screened and evaluated for quality. RevMan 5.3 software was used for meta-analysis. Results A total of five articles were included. There were no significant differences in mortality (RR = 0.61, 95%CI: 0.20-1.88, P = 0.39) and incidence of cerebral hemorrhage after thrombolysis (RR = 0.86, 95%CI: 0.31-2.41, P = 0.77) between the two groups. The 60 min thrombolytic rate (RR = 1.44, 95%CI: 1.16-1.78, P = 0.001) and thrombolytic decision agreement rate (RR = 1.12, 95%CI: 1.01-1.25, P = 0.03) in the experimental group were higher than those in the control group, and the differences were statistically significant. Conclusion Decision aids in patients with first stroke can improve the 60 min thrombolytic rate and thrombolytic decision agreement rate, and it is safe, which is worthy of further clinical research and promotion.
Key wordsDecision aids    Stroke    Meta-analysis    Systematic review
    
基金资助:江苏省卫生健康委科研项目(Z2020028)。
通讯作者: ▲通讯作者   
作者简介: 张敏(1991.9-),女,硕士;研究方向:临床护理。
引用本文:   
张敏1 丁晓彤2 李现文3▲. 决策辅助在首次脑卒中患者中应用效果的系统评价[J]. 中国医药导报, 2022, 19(17): 84-87.
ZHANG Min1 DING Xiaotong2 LI Xianwen3▲. Systematic evaluation of decision aids in patients with first stroke. 中国医药导报, 2022, 19(17): 84-87.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/     或     https://www.yiyaodaobao.com.cn/CN/Y2022/V19/I17/84

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司